|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | APACHE II、BISAP、Ranson评分和改良CTSI对急性胰腺炎严重程度(基于Atlanta 2012分类)预测价值的比较显示文摘目的:本研究前瞻性比较了急性生理和慢性健康状况评分(APACHEⅡ)、急性胰腺炎严重程度床边指数(BISAP)、Ranson评分与改良CT严重度指数(CTSI)这四种方法,评估印度北部一家三甲医院急性胰腺炎患者疾病严重程度(基于Atlanta 2012分类)的准确性。方法:前瞻性纳入2015年3月至2016年9月间我院收治的50例急性胰腺炎患者,对所有入组病例进行APACHEⅡ、BISAP和Ranson评分,并基于胰腺对比增加CT进行改良CTSI评估。基于受试者工作特征(ROC)曲线评估这些评分系统预测急性胰腺炎严重程度的最佳阈值和曲线下面积(AUC),并对这些评分系统的预测价值进行前瞻性比较。结果:50例急性胰腺炎患者中14例被评估为重症急性胰腺炎。15例患者出现胰腺坏死,14例出现持续器官功能衰竭,14例需要收治重症监护室(ICU)。改良CTSI对重症急性胰腺炎、胰腺坏死、器官衰竭、入住ICU的预测价值均为最高,其AUC分别为0.919、0.993、0.893和0.993。APACHEⅡ对重症急性胰腺炎和器官衰竭的预测价值均仅次于改良CTSI,其AUC分别为0.934和0.931。APACHEⅡ对胰腺坏死、器官衰竭、入住ICU的预测具有较高的敏感性(分别为93.33%、92.86%和92.31%)和阴性预测值(分别为96.15%、96.15%和95.83%)。结论:APACHEⅡ是预测急性胰腺炎严重程度的一项有效的评估系统,有助于筛选出病情危重、需要早期复苏和尽快转诊上级医院的急性胰腺炎患者,尤其在一些医疗资源匮乏的发展中国家。 | Anubhav Harshit Kumar Mahavir Singh Griwan | 2018 | Gastroenterology Report2018，6，2： | 27 |
| 2 | 胃肠道癌:中国、美国和欧洲显示文摘胃肠道癌包括结直肠癌、胃癌和食管癌,给全球带来了沉重的医疗和经济负担,无论是每年新发病例数还是死亡例数,均居癌症首位。食管癌和胃癌多见于发展中国家,而结直肠癌则是西方国家的主要胃肠道恶性肿瘤。然而,一些经济转型的发展中国家,其胃肠道癌谱正在发生巨大转变,同时,在西方国家,由于某些危险因素的暴露增加,食管癌和胃癌也有抬头的趋势。所有胃肠道癌的发生发展均与生活习惯密切相关,而且都能通过癌前病变予以识别。因此,这些胃肠道癌都非常适宜早期筛查。本文中,我们综述了胃肠道癌在中国、美国、欧洲的流行病学特点,总结其主要危险因素以及这些危险因素在上述地区的分布情况,并对当前的筛查策略进行了探讨。 | Yumo Xie Lishuo Shi Xiaosheng He Yanxin Luo | 2021 | Gastroenterology Report2021，9，2： | 16 |
| 3 | 肠道菌群在功能性便秘中的作用显示文摘功能性便秘非常常见,但其发病机制尚不明了。越来越多的证据显示,功能性便秘与肠道微生态失调有关,而肠道微生态与肠道转运之间很可能存在相互影响。本文对功能性便秘发生过程中肠道微生态所发挥作用的证据进行了总结。肠道微生态通过胆酸、短链脂肪酸、5-羟色胺和甲烷等相关微生物代谢活动调控结肠动力、结肠黏膜分泌和吸收,进而促使功能性便秘的发生。作为肠道微生态影响功能性便秘的证据支持,用益生菌、益生元、合生元和中药治疗功能性便秘时,常可观察到患者肠道微生态在菌种组成和功能上的改变。深入研究功能性便秘的病理发生,阐明微生态制剂治疗功能性便秘的药理机制,将为功能性便秘的新型治疗方法提供理论基础。 | Shengsheng Zhang Ruixin Wang Danyan Li Luqing Zhao Lixin Zhu | 2021 | Gastroenterology Report2021，9，5： | 13 |
| 4 | 粪菌移植应用于慢传输型便秘的临床疗效及疗效影响因素:一项前瞻性研究的长期随访结果显示文摘背景和目的肠道菌群参与结肠动力的调控,菌群失调是便秘是病因之一。粪菌移植被证实可以恢复肠道平衡。本研究旨在评估粪菌移植治疗慢传输型便秘(STC)的临床疗效和预后影响因素。方法:52例STC患者接受标准的粪菌移植入组研究,对其进行至少6个月的随访。记录入组患者的排便习惯、结肠传输时间、便秘相关的症状(PAC-SYM评分)、生活质量(PAC-QOL评分)、治疗满意度和不良反应。主要疗效指标是平均每周完全自主排便≥3次的患者比例。结果:治疗后34周、912周、2124周,每周完全自主排便≥3次患者的比例分别为50.0%、38.5%和32.7%,均较治疗前显著提高(均P<0.01)。其他排便情况、结肠传输时间、便秘相关症状和生活质量方面,治疗后亦有显著改善;但这些短期改善在治疗后12周和24周逐渐减小。治疗前排便不尽是唯一的疗效影响因素。治疗和随访期间未发现任何治疗相关的不良反应。结论:本研究显示粪菌移植治疗STC安全有效,但远期疗效有所降低。治疗前排便不尽感较少甚至没有的患者接受粪菌移植的治疗效果更佳。 | Chao Ding Wenting Fan Lili Gu Hongliang Tian Xiaolong Ge Jianfeng Gong Yongzhan Nie Ning Li | 2018 | Gastroenterology Report2018，6，2： | 7 |
| 5 | 肠道黏液层如何应对肠道菌群:抗击还是哺育?显示文摘肠道居住着大量微生物,即所谓的肠道菌群。这些微生物与宿主是一种共生关系,可协助宿主降解复杂的碳水复合物。尽管肠道菌群通常被认为是有益的,但大量存在的微生物细胞对宿主来说也是一种永久性的威胁。因此,肠道上皮覆以一层致密的黏液层,以防止肠道菌群进入下层组织。肠道黏液是一种有着宿主特异性多糖结构的糖蛋白网络。黏液层长久以来一直被认为是一种被动的、宿主设计的屏障,但最新研究显示,黏液层的成熟和功能在很大程度上受肠道菌群的影响。反过来,一些黏膜相关的细菌也能特异性地与黏蛋白中的多糖链结合或降解之,将其作为营养来源。由于肠道黏液层处于宿主与微生物相互作用的关键界面,该层结构的损坏会导致肠道菌群的侵入并最终引起炎症和感染。于是我们在结肠炎大鼠模型和结肠炎患者中,可以观察到黏液层的功能丧失。而且,现代社会中低纤维的西方饮食已被证实会引起细菌介导的肠道黏液层结构损害。在此,本文对健康状态和疾病状态下肠道菌群与肠道黏液层之间的相互作用进行阐述。了解宿主与微生物之间相互作用的具体分子机制,或可研发出针对黏液层功能失调相关疾病(如溃疡性结肠炎)新的治疗手段。 | Bjoern O.Schroeder | 2019 | Gastroenterology Report2019，7，1： | 7 |
| 6 | 溃疡性结肠炎内镜下严重度指数(UCEIS评分)与Mayo内镜评分(MES)用于预测急性重症结肠炎患者行肠切除术的比较研究显示文摘背景溃疡性结肠炎内镜下严重度指数(UCEIS)和Mayo内镜评分(MES)都是溃疡性结肠炎(UC)内镜下严重程度的客观评估方法,然而,对于这两种评分方法能否用于筛选出需要行结肠切除术的急性重症结肠炎患者,目前仍不明了。方法:对2012年1月至2016年5月间连续收治的ASC患者进行回顾性分析。提取并分析入组患者的人口统计资料、既往治疗史、疾病特征资料、实验室指标、药物治疗及内镜评估等资料。主要结局指标是住院和随访期间需行结肠切除术的患者比例。结果:92例患者纳入研究,其中37例(40.2%)需行结肠切除术。多因素分析显示,UCEIS评分是需行结肠切除术的独立预测因素(OR=3.25,95%CI:1.77~5.97;P<0.001)。UCEIS评分的ROC曲线下面积为0.85;以7分作为最佳阈值,其预测需行结肠切除术的敏感度为60.3%,特异度为85.5%。UCEIS评分对于需要行结肠切除术的预测价值优于MES评分,后者曲线下面积仅为0.65。当UCEIS评分≥7分时,有80%的ASC患者最终需行结肠切除术。结论:预测ASC患者的肠切除风险,UCEIS评分优于MES评分。对于USEIS≥7分的患者,由于其药物治疗失败风险较高,因此,可考虑早期行结肠切除术。 | Tingbin Xie Tenghui Zhang Chao Ding Xujie Dai Yi Li Zhen Guo Yao Wei Jianfeng Gong Weiming Zhu Jieshou Li | 2018 | Gastroenterology Report2018，6，1： | 6 |
| 7 | 直肠癌根治术中的盆腔自主神经保护:30年变迁显示文摘全直肠系膜切除(TME)理念及微创技术(如腹腔镜结直肠手术和机器人手术)的出现大大提高直肠癌的外科疗效。然而,术后排尿功能和性功能障碍率仍然较高,从而给患者造成巨大的痛苦,同时也会给手术医生带来困扰。新辅助和辅助放疗应用的增多也带来了更多的功能问题。在本文中,我们对盆腔神经解剖的目前认识进行了评价,将盆腔神经分为肠系膜下动脉根部、侧盆壁及泌尿生殖器官周围等区域,探讨了在这些区域如何进行手术操作。同时,我们也讨论了过去30年不同手术方式(包括开腹、腹腔镜和机器人)的功能状况。 | Min-Hoe Chew Yu-Ting Yeh Evan Lim Francis Seow-Choen | 2016 | Gastroenterology Report2016，4，3： | 5 |
| 8 | Historical development of mesenteric anatomy provides a universally applicable anatomic paradigm for complete/total mesocolic excision显示文摘Although total mesorectal excision has now become the‘gold standard’for the surgical management of rectal cancer,this is not so for colon cancer.Recent data,provided by Hohenberger and West et al.and others,have demonstrated excellent oncological outcomes when mesenterectomy is extensive(as is implicit in the concept of a‘high tie’)and the mesenteric package not violated.Such studies highlight the importance of understanding the basics of the mesenteric organ(including the small intestinal mesentery,mesocolon,mesosigmoid and mesorectum)and of abiding to principles of planar surgery.In this review,we first offer classic descriptions of the mesocolon and then detail contemporary thinking.In so doing,we provide an anatomical basis for safe and effective complete mesocolic excision(CME)in the management of colon cancer.Finally we list opportunities associated with the new anatomical paradigm,demonstrating benefits across multiple disciplines.Perhaps most importantly,we feel that a crystallized view of mesenteric anatomy will overcome factors that have hindered the general uptake of CME. | Rishabh Sehgal J.Calvin Coffey | 2014 | Gastroenterology Report2014，2，4： | 5 |
| 9 | 新辅助放化疗加直肠癌切除术后外科切缘的放射性损伤:吻合口漏的预判线索显示文摘背景:对于直肠癌切除术后吻合口状态及其对吻合口漏的影响,目前鲜有研究报道。本研究旨在分析新辅助放化疗+直肠前切除术后外科切缘可能受到的放射性损伤,以及其与吻合口漏发生的关系。方法:回顾性纳入2014-2015年间连续收治的161例直肠前切除手术患者,包括行新辅助放化疗、单纯新辅助化疗或未行术前新辅助治疗者。采用一种专门的组织病理学评分和黏膜下层微血管密度,来对手术切缘标本进行评估。采用倾向评分匹配方法来平衡基线资料。分析吻合口漏与组织病理学特征的相关性。结果:54例新辅助放化疗患者中13例术后发生吻合口漏,48例新辅助化疗患者中5例术后发生吻合口漏,而59例未行新辅助治疗的患者中有7例出现术后吻合口漏。倾向评分匹配后,新辅助放化疗、新辅助化疗和未行新辅助治疗三组患者近切缘组织病理评分中位数(范围)分别为3(0-8)、0(0-3)和0(0-2)(P<0.001),远切缘组织病理评分分别为4(2-9)、0(0-4)和0(0-3)(P<0.001);近切缘微血管密度平均数(标准差)分别为21.7(7.9)、27.2(8.6)和27.3(9.4)(P=0.003),远切缘微血管密度分别为18.1(9.3)、25.2(12.9)和24.9(7.4)(P<0.001)。在新辅助放化疗患者中,吻合口漏的发生与组织病理学评分增高(P=0.003)及微血管密度减少(P=0.004)密切相关。结论:新辅助放化疗后,直肠癌切除术的外科切缘存在一定程度的放射性损伤。近切缘放射性损伤越严重,吻合口漏发生概率越高。 | Qiyuan Qin Yaxi Zhu Peihuang Wu Xinjuan Fan Yan Huang Binjie Huang Jianping Wang Lei Wang | 2019 | Gastroenterology Report2019，7，2： | 5 |
| 10 | 评述“经自然腔道标本取出术(NOSES)治疗结直肠癌的国际共识”显示文摘Natural-orifice specimen-extraction surgery(NOSES)for colorectal disease is not a new surgical procedure,although its lack of penetration into common colorectal surgical practice may make it a relatively new procedure.Stewart et al.[1]were among the first to report the extraction of a colectomy specimen through the vagina in 1991 and,shortly thereafter,Franklin et al.[2]published the first report of partial colectomy with naturalorifice specimen extraction(NOSE)via the anus.Since then,there have been several publications on the extraction of both malignant and benign colonic diseases from the caecum to the distal rectum through natural-orifice extraction sites.Unlike procedures such as laparoscopic cholecystectomy,which was introduced in 1985 and rapidly diffused into the surgical community over a 2-to 3-year period,the dispersion of NOSES has not been equivocal[3].As there are several reasons why some new surgical innovations may be taken up more quickly than others,the adoption curves of new procedures can take many forms.However,the tipping point that describes the onset of the peak rate of diffusion of the new technology usually occurs after the first 10%–20%of users have adopted it[3].From a global perspective,the adoptions curve for NOSES has not obtained a peak rate of diffusion and appears to have arrested in the developmental and explorative phase of innovation[3]. | Joseph W.Nunoo-Mensah Mariam Rizk | 2020 | Gastroenterology Report2020，8，6： | 5 |
| 11 | 营养不良:实验室指标vs营养评估显示文摘营养不良是患者并发症发生率和病死率的一项独立危险因素,并造成医疗费用的增高。然而,由于对营养不良没有一个统一的定义,也没有一个标准的营养不良筛查/诊断方法,导致全世界各地的医生对营养不良在认识上十分混乱,各地的临床实践也有着各不相同的标准。作为营养不良的危险因素,炎症的作用近期已被证实。组织学上,一些血清蛋白如白蛋白和前白蛋白被广泛用于监测患者的营养状态。然而,目前的研究热点是采用恰当的营养状态体格检查(NFPE)来诊断营养不良。目前认为,实验室指标本身不太可靠,只能作为NFPE的一个补充。今后的研究中需要筛选出一些诊断营养不良的血清生物学标志物,这些标志物必须是不受炎症状态影响且具有无创及价格相对低廉的优势。然而,一个完全的NFPE在营养不良的诊断中具有无可替代的作用。 | Shishira Bharadwaj Shaiva Ginoya Parul Tandon Tushar D.Gohel John Guirguis Hiren Vallabh Andrea Jevenn Ibrahim Hanouneh | 2016 | Gastroenterology Report2016，4，4： | 5 |
| 12 | Refractory gastroesophageal reflux disease显示文摘Gastroesophageal reflux disease(GERD)is a condition that develops when the reflux of stomach contents into the esophagus causes troublesome symptoms,esophageal injury,and/or complications.Use of proton pump inhibitors(PPI)remains the standard therapy for GERD and is effective in most patients.Those whose symptoms are refractory to PPIs should be evaluated further and other treatment options should be considered,according to individual patient characteristics.Response to PPIs could be total(no symptoms),partial(residual breakthrough symptoms),or absent(no change in symptoms).Patients experiencing complete response do not usually need further management.Patients with partial response can be treated surgically or by using emerging endoscopic therapies.Patients who exhibit no response to PPI need further evaluation to rule out other causes. | Charumathi Raghu Subramanian George Triadafilopoulos | 2015 | Gastroenterology Report2015，3，1： | 5 |
| 13 | 胃食管反流病:内镜评估与治疗方面的革新显示文摘内镜技术的创新为胃食管反流病(GERD)的诊治带来了巨大进步。作为世界上最常见的胃肠疾病之一,GERD一直是内镜介入治疗的前沿。目前,GERD的初步诊断是基于症状和质子泵抑制剂(PPI)初期治疗有效,但这对治疗策略的指导价值有限。然而,内镜检查和病理活检可直接观察和判断食管的异常结构和病理生理损伤;同时,内镜治疗的出现给PPI治疗依从性较差或治疗反应不佳以及不适合行胃底折叠抗反流手术的患者提供了新的治疗选择。本综述对内镜检查和活检在经过恰当的抗反流药物治疗后持续存在GERD相关临床表现的患者中的应用情况进行了概述,并介绍了目前内镜治疗GERD的各项新技术及其优缺点。今后的研究需要对GERD患者进行分层研究,并力图阐明该疾病的主要病理生理机制。 | Sheng Chen Feng Du Changqing Zhong Caifang Liu Xiaoying Wang Yan Chen Gang Wang Xiaopei Gao Lu Zhang Lianyong Li Wei Wu | 2021 | Gastroenterology Report2021，9，5： | 4 |
| 14 | Transanal total mesorectal excision combined with intersphincteric resection has similar long-term oncological outcomes to laparoscopic abdominoperineal resection in low rectal cancer:a propensity score-matched cohort study显示文摘Background Transanal total mesorectal excision(taTME)or intersphincteric resection(ISR)has recently proven to be a valid and safe surgical procedure for low rectal cancer.However,studies focusing on the combination of these two technologies are limited.This study aimed to evaluate perioperative results,long-termoncologic outcomes,and anorectal functions of patients with low rectal cancer undergoing taTME combined with ISR,by comparing with those of patients undergoing laparoscopic abdominoperineal resection(laAPR).Methods After 1:1 propensity score matching,200 patients with low rectal cancer who underwent laAPR(n=100)or taTME combined with ISR(n=100)between September 2013 and November 2019 were included.Patient demographics,clinicopathological characteristics,oncological outcomes,and anal functional results were analysed.Results Patients in the taTME-combined-with-ISR group had less intraoperative blood loss(79.6672.6 vs 107.3665.1 mL,P=0.005)and a lower rate of post-operative complications(22.0%vs 44.0%,P<0.001)than those in the laAPR group.The overall local recurrence rates were 7.0%in both groups within 3 years after surgery.The 3-year disease-free survival rates were 86.3%in the taTME-combined-with-ISR group and 75.1%in the laAPR group(P=0.056),while the 3-year overall survival rates were 96.7%and 94.2%,respectively(P=0.319).There were 39 patients(45.3%)in the taTME-combined-with-ISR group who developed major low anterior resection syndrome,whereas 61 patients(70.9%)had good post-operative anal function(Wexner incontinence score≤10).Conclusion We found similar long-term oncological outcomes for patients with low rectal cancer undergoing laAPR and those undergoing taTME combined with ISR.Patients receiving taTME combined with ISR had acceptable post-operative anorectal function. | Zhi-Hang Liu Zi-Wei Zeng Hai-Qing Jie Liang Huang Shuang-Ling Luo Wen-Feng Liang Xing-Wei Zhang Liang Kang | 2022 | Gastroenterology Report2022，10，1： | 4 |
| 15 | The burden of IBS: Looking at metrics显示文摘 | Brennan M. R. Spiegel | 2009 | Current Gastroenterology Reports2009，，4： | 4 |
| 16 | One stomach,two subtypes of carcinoma—the differences between distal and proximal gastric cancer显示文摘Gastric cancer(GC)is one of the most common malignant tumors of the digestive tract,posing a significant risk to human health.Over the past 10 years,the pathological characteristics and the prognosis of GC have been determined based on the locations of the tumors that were then classified into two types—proximal and distal GC.This review focuses on the differences in epidemiology,etiology,cell source,pathological characteristics,gene expression,molecular markers,manifestations,treatment,prognosis,and prevention between proximal and distal GC to provide guidance and a basis for clinical diagnosis and treatment. | Yuan Zhang Peng-Shan Zhang Ze-Yin Rong Chen Huang | 2021 | Gastroenterology Report2021，9，6： | 4 |
| 17 | 腹腔镜根治性右半结肠切除经肛标本取出:一种新的经自然腔道取标本术式显示文摘Introduction The main treatment for colon cancer is surgery;however,conventional surgery causes great suffering due to the huge abdominal incision.The advent of laparoscopic surgery has greatly reduced abdominal-wall damage and pain,but anastomosis and the specimen-removal process still require creation of an incision in the abdominal wall.In 1993,Franklin et al.[1]described a case of totally laparoscopic colectomy with transanal specimen extraction as the first natural-orifice specimenextraction surgery(NOSES)and this has been considered the most preferable procedure owing to the absence of abdominal incision,mild post-operative pain,and rapid recovery. | Peng Sun Zheng Liu Xu Guan Shou Luo Xu-Hao Cai Jing-Wen Li Xi-Shan Wang | 2021 | Gastroenterology Report2021，9，2： | 4 |
| 18 | Comparing the clinical application values of the Degree of Ulcerative Colitis Burden of Luminal Inflammation(DUBLIN)score and Ulcerative Colitis Endoscopic Index of Severity(UCEIS)in patients with ulcerative colitis显示文摘Background:The significance of endoscopic evaluation in the diagnosis and management of ulcerative colitis(UC)has been widely recognized.Over the years,scholars have established several endoscopic scores.Herein,we assessed the clinical application value of the Mayo Endoscopic Subscore(Mayo ES),the Degree of Ulcerative Colitis Burden of Luminal Inflammation(DUBLIN)score,and the Ulcerative Colitis Endoscopic Index of Severity(UCEIS)score in UC patients,by comparing their correlation with disease activity and their predictive potential for treatment response and clinical outcomes.Methods:UC patients hospitalized from September 2015 to September 2019 were retrospectively analysed.We employed Spearman’s rank correlation coefficient to assess the linear association of the assessed endoscopic scores with the clinical parameters.The receiver-operating characteristic curve was applied to evaluate the predictive capabilities of the endoscopic scores for treatment escalation and 1-year readmission.Results:A total of 178 patients were enrolled;most of them(82%)suffered moderate or severe colitis.Among them,48(27%)patients received treatment escalation and 59(33%)were readmitted within 1 year.The DUBLIN and UCEIS scores demonstrated higher correlations with clinical parameters than the Mayo ES.The DUBLIN scores significantly differed between patients with mild,moderate,and severe colitis(all P<0.001).The UCEIS scores demonstrated the best predictabilities for treatment escalation and 1-year readmission with an area under the curve of 0.88 and 0.75,respectively.Compared to the UCEIS and DUBLIN scores,the predictive capabilities of the Mayo ES for treatment escalation(both P<0.001)and 1-year readmission(P<0.001 and P紏0.002,respectively)were lower.The UCEIS scores exhibited a significant difference between the steroid-responsive group and the steroid-dependent or steroid-refractory group(both P<0.001),while no significant differences in the Mayo ES and DUBLIN scores were found among the three groups(both P>0.05).Conclusion:This study demonstrates that both the DUBLIN and UCEIS scores outperform the Mayo ES in assessing disease severity and predicting treatment response and clinical outcomes in UC patients. | Xiao-Fei Zhang Peng Li Xue-Li Ding Hao Chen Shao-Jun Wang Sheng-Bo Jin Jing Guo Zi-Bin Tian | 2021 | Gastroenterology Report2021，9，6： | 4 |
| 19 | Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress显示文摘 | Young S. Kim Samuel B. Ho | 2010 | Current Gastroenterology Reports2010，，5： | 4 |
| 20 | 经自然腔道取标本手术(NOSES)治疗结直肠癌的国际共识显示文摘近年来,经自然腔道取标本手术(NOSES)治疗结直肠癌已引起了广泛关注。NOSES应用于结直肠手术的潜在优势包括减轻术后疼痛,减少伤口并发症,减少对术后镇痛的需求,加快肠道功能的恢复,缩短住院时间,更好的美容效果,以及给患者带来了更佳的心理状态。尽管NOSES的手术创伤显著减轻,然而该技术也存在一些潜在问题。尤其随着这项新技术的兴起,人们对其无菌的把控、肿瘤学结果和病例选择等问题表示出关切。因此,迫切需要一部操作指南来规范NOSES手术在结直肠癌中的开展。经过国际NOSES联盟全体成员的三轮讨论,最终形成了该部共识。这一共识有助于NOSES在全球范围内的长远发展。 | Xu Guan Zheng Liu Antonio Longo Jian-Chun Cai William Tzu-Liang Chen Lu-Chuan Chen Ho-Kyung Chun Joaquim Manuel da Costa Pereira Sergey Efetov Ricardo Escalante Qing-Si He Jun-Hong Hu Cuneyt Kayaalp Seon-Hahn Kim Jim S.Khan Li-Jen Kuo Atsushi Nishimura Fernanda Nogueira Junji Okuda Avanish Saklani Ali A.Shafik Ming-Yin Shen Jung-Tack Son Jun-Min Song Dong-Hui Sun Keisuke Uehara Gui-Yu Wang Ye Wei Zhi-Guo Xiong Hong-Liang Yao Gang Yu Shao-Jun Yu Hai-Tao Zhou Suk-Hwan Lee Petr V.Tsarkov Chuan-Gang Fu Xi-Shan Wang The International Alliance of NOSES | 2019 | Gastroenterology Report2019，7，1： | 3 |
您所在的机构暂未开通此部分的功能，请联系管理员